<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, public health officials are counting on vaccines as the first line of pandemic defence. The World Health Organization (WHO) has led a vigorous effort to expand seasonal influenza vaccine production in low- and middle-income countries, including India
 <xref rid="ref7" ref-type="bibr">7</xref>
 <xref rid="ref8" ref-type="bibr">8</xref>. Seasonal influenza is responsible for appreciable morbidity and mortality in developing countries
 <xref rid="ref9" ref-type="bibr">9</xref>, and expanded vaccine production might reduce this burden by improving vaccination rates. International trends, however, are not encouraging. An ongoing survey of 201 countries has shown that annual influenza vaccine distribution rates in many countries have plateaued, and in some, the rates are actually falling
 <xref rid="ref10" ref-type="bibr">10</xref>. In the countries of Southeast Asia, the eastern Mediterranean and Africa, which account for at least half the global population, hardly any seasonal influenza vaccine is used. Moreover, it will take time to produce pandemic vaccines, so they will not be available in any country during the first six pandemic months
 <xref rid="ref11" ref-type="bibr">11</xref>.
</p>
